Pathology associated memory deficits in Swedish mutant genome-based amyloid precursor protein transgenic mice

Current Aging Science

Volumn 2, Issue 3, 2009, Pages 205-213

  Hock, Brian J ^a   Lattal, K Matthew ^b   Kulnane, Laura Shapiro ^c   Abel, Ted ^d   Lamb, Bruce T ^c,e  

^a AUSTIN PEAY STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

A deposits; Alzheimer's disease; APP; Learning; Memory; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COMPLEMENTARY DNA; CELL SURFACE RECEPTOR; PROTEASE NEXINS;

AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; LEARNING; LONG TERM MEMORY; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SWEDEN; WORKING MEMORY; AGE; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; GENETICS; HUMAN; MEMORY; MEMORY DISORDER; METABOLISM; MUTATION; PATHOLOGY; PSYCHOLOGICAL ASPECT; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; RECEPTORS, CELL SURFACE;

EID: 77649198741     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609810902030205     Document Type: Article

References (50)

1. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 2000; 21(6): 845-61.
2. Fleischman DA and Gabrieli J. Long-term memory in Alzheimer's disease. Curr Opin Neurobiol 1999; 9(2): 240-4.
3. Hock BJ, Jr. and Lamb BT. Transgenic mouse models of Alzheimer's disease. Trends Genet 2001; 17(10): S7-12.
4. Eriksen JL and Janus CG. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 2007; 37(1): 79-100.
5. Lamb BT, Bardel KA, Kulnane LS, Anderson JJ, Holtz G, Wagner SL, et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 1999; 2(8): 695-7.
6. Lamb BT, Call LM, Slunt HH, Bardel KA, Lawler AM, Eckman CB, et al. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet 1997; 6(9): 1535-41.
7. Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K and Lamb BT. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J Neurosci 2008; 28(43): 10786-93.
8. Yang Y, Varvel NH, Lamb BT and Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 2006; 26(3): 775-84.
9. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet 1993; 5(1): 22-30.
10. Kulnane LS and Lamb BT. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice. Neurobiol Dis 2001; 8(6): 982-92.
11. Lehman EJ, Kulnane LS and Lamb BT. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol Aging 2003; 24(5): 645-53.
12. Frankland PW and Bontempi B. The organization of recent and remote memories. Nat Rev Neurosci 2005; 6(2): 119-30.
13. Teixeira CM, Pomedli SR, Maei HR, Kee N and Frankland PW. Involvement of the anterior cingulate cortex in the expression of remote spatial memory. J Neurosci 2006; 26(29): 7555-64.
14. Wang SH, Teixeira CM, Wheeler AL and Frankland PW. The precision of remote context memories does not require the hippocampus. Nat Neurosci 2009; 12(3): 253-5.
15. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 2002; 26(1): 91-104.
16. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K and Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 1999; 29(3): 177-85.
17. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274(5284): 99-102.
18. King DL, Arendash GW, Crawford F, Sterk T, Menendez J and Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 1999; 103(2): 145-62.
19. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C and Strazielle C. Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 2002; 956(1): 36-44.
20. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2002; 22(5): 1858-67.
21. Kulnane LS, Lehman EJ, Hock BJ, Tsuchiya KD and Lamb BT. Rapid and efficient detection of transgene homozygosity by FISH of mouse fibroblasts. Mamm Genome 2002; 13(4): 223-6.
22. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4(1): 97-100.
23. Morgan D. Water maze tasks in mice: Special reference to Alzheimer's transgenic mice. In: Buccafusco JJ, Ed. Methods of Behavior Analysis in Nueroscience. Boca Taon, FL: CRC Press 2009.
24. Lattal KM and Abel T. Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. J Neurosci 2001; 21(15): 5773-80.
25. Kim KS, Wen GY, Bancher C, Chen CMJ, Sapienza VJ, Hong H, et al. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Commun 1990; 7: 113-22.
26. Franklin KBJ and Paxinos G. The mouse brain in stereotaxic coordinates. New York: Academic Press 2008.
27. Kirk RE. Experimental design, procedures for the behavioral sciences. Monterey, Calif., Brooks/Cole 1994.
28. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000; 283(12): 1571-7.
29. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14(8): 837-42.
30. Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 2008; 192(1): 106-13.
31. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002; 924(2): 133-40.
32. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007; 27(4): 796-807.
33. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ and Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27(11): 2866-75.
34. Lesne S, Kotilinek L and Ashe KH. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 2008; 151(3): 745-9.
35. King DL and Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 2002; 75(5): 627-42.
36. Delaere P, Duyckaerts C, Masters C, Beyreuther K, Piette F and Hauw JJ. Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 1990; 116(1-2): 87-93.
37. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992; 13(1): 179-89.
38. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23(2): 138-44.
39. Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 2007; 68(19): 1603-6.
40. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007; 130(Pt 11): 2837-44.
41. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 1997; 6(11): 1951-9.
42. Del Vecchio RA, Gold LH, Novick SJ, Wong G and Hyde LA. Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett 2004; 367(2): 164-7.
43. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408(6815): 979-82.
44. Lalonde R, Dumont M, Staufenbiel M and Strazielle C. Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res 2005; 157(1): 91-8.
45. Moechars D, Lorent K, De Strooper B, Dewachter I and Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996; 15(6): 1265-74.
46. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 1995; 15(5): 1203-18.
47. Kumar-Singh S, Dewachter I, Moechars D, Lubke U, De Jonghe C, Ceuterick C, et al. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 2000; 7(1): 9-22.
48. Moechars D, Gilis M, Kuiperi C, Laenen I and Van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport 1998; 9(16): 3561-4.
49. Vloeberghs E, Van Dam D, Coen K, Staufenbiel M and De Deyn PP. Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci 2006; 120(6): 1380-3.
50. Kelly PH, Bondolfi L, Hunziker D, Schlecht HP, Carver K, Maguire E, et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol Aging 2003; 24(2): 365-78.